Skip to main content
Erschienen in: Updates in Surgery 8/2023

Open Access 02.11.2023 | Review Article

Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a systematic review of propensity score-matched studies

verfasst von: Ya-Fei Hu, Hai-Jie Hu, Wen-Jie Ma, Yan-Wen Jin, Fu-Yu Li

Erschienen in: Updates in Surgery | Ausgabe 8/2023

Abstract

Outcomes of laparoscopic liver resection (LLR) versus open LR (OLR) for intrahepatic cholangiocarcinoma (ICCA) are heterogeneous. We aimed to compare LLR and OLR for ICCA based on propensity-score-matched (PSM) studies. Two reviewers independently searched the online databases (PubMed, Embase, and Cochrane Library) for PSM studies that compared LLR and OLR for ICCA. The Ottawa–Newcastle Quality Assessment Scale with a cutoff of ≥ 7 was used to define higher-quality literature. Only ‘high-quality’ PSM analyses of the English language that met all our inclusion criteria were considered. A total of ten PSM trials were included in the analyses. Compared with OLR, although the lymph node dissection (LND) (RR = 0.67) and major hepatectomy rates were lower in the LLR group (RR = 0.87), higher R0 resections (RR = 1.05) and lower major complications (Clavien–Dindo grade ≥ III) (RR = 0.72) were also observed in the LLR group. In addition, patients in the LLR group showed less estimated blood loss (MD = − 185.52 ml) and shorter hospital stays as well (MD = − 2.75 days). Further analysis found the overall survival (OS) (HR = 0.91), disease-free survival (DFS) (HR = 0.95), and recurrence-free survival (HR = 0.80) for patients with ICCA after LLR were all comparable to those of OLR. LLR for selected ICCA patients may be technically safe and feasible, providing short-term benefits and achieving oncological efficacy without compromising the long-term survival of the patients.

Introduction

Intrahepatic cholangiocarcinoma (ICCA) and hepatocellular carcinoma (HCC) are the most seen primary liver cancers (PLC). Studies reported most PLCs were HCC (> 80%), and ICCA only accounted for 10–15% [1]. Compared with HCC, ICCA is rarer, and there is a lack of large population-based or randomized-controlled studies (RCT) of ICCA treatment. Reviewing existing literature for evidence of ICCA treatment is required [25].
There are significant differences between HCC and ICCA [6] when regarding the patient's basic demographic characteristics and tumor biological features. Patients with ICCA usually had a worse prognosis, with 5-year overall survival (5-OS) being 20–40% versus that of 50–70% for patients with HCC. Studies have also found that ICCA patients tend to present a more advanced tumor burden compared to HCC, including a higher rate of lymph node involvement (27.6% vs. 7.7%) and larger tumor size (proportion of tumors ≥ 5 cm (63.7% vs. 46.3%)) [1]. Therefore, although laparoscopic liver resection (LLR) is gaining momentum for HCC [1, 7, 8], evidence of LLR application for ICCA has not been quantified in the aggregate [913].
Due to inferior tumor biological behaviors, the difficulty of hilar lymph node dissection (LND), and hepato-biliary reconstruction, LLR application for ICCA is in the initial phase and mainly reserved in high-volume experienced medical centers. Most existing studies including meta-analyses (MAs) had reported LLR for selected ICCA patients was technically safe and feasible, with comparable oncological outcomes to the open LR (OLR) [10, 14, 15]. Contradictory results were still reported from several studies [16].The safety, feasibility, and oncological efficiency of LLR for ICCA are related to ICCA tumor stages and the surgeons’ experience. Therefore, significant heterogeneity is presented in published studies. Moreover, postoperative complications and survival outcomes after either LLR or OLR may vary with the availability of efficacious antitumor therapies and improved perioperative management over time. Thus, published systematic reviews need to be updated with high-quality propensity-score-matched (PSM) studies.
Based on the reasons above, we aimed to compare both perioperative-related and long-term survival outcomes of LLR and OLR in patients with ICCA through a meta-analytic approach. Only recently published PSM studies of high quality were included in analyses.

Materials and methods

The protocol for this study had been registered at PROSPERO (CRD42022348032). Our paper followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 [17].
Two reviewers (Author 1 and Author 2) systematically searched online databases including PubMed, Cochrane Library, and Embase from data inception to May 12, 2023, to find studies that might be suitable for our meta-analyses. The search strategy was based on the PICOS principle, combining MESH and their associated/related terms. The search items were presented as follows: ‘Intrahepatic cholangiocarcinoma [MeSH Terms]’ and ‘open liver resection [MeSH Terms]’ and ‘laparoscopic liver resection [MeSH Terms]’ and ‘propensity score-matched analyses [MeSH Terms]’ or ‘open liver surgery’ or ‘open hepatectomy’ or ‘minimally invasive liver resection’ or ‘minimally invasive hepatectomy’ or ‘laparoscopic hepatectomy’ or ‘PSM analyses’ or ‘matched studies’ or ‘ICCA’ or ‘Intrahepatic cholangiocarcinomas’. More detailed search terms are presented in Supplementary Table S3.
The entire texts of possibly qualifying papers were reviewed by the same 2 reviewers (Author 1 and Author 2) separately. A third reviewer (Corresponding Author) was consulted to settle any disagreements met. To avoid literature that might be ignored during our search, we reviewed the citations of retrieved eligible articles as well as the conference proceedings manually. Besides, to avoid missing studies that were published after our first search, we performed re-research before the submission on June 15, 2023.

Inclusion criteria

Studies that were eligible for the meta-analyses should meet the following criteria:
i.
PSM studies of the English language.
 
ii.
All including patients were pathologically diagnosed with ICCA after postoperative pathological diagnosis.
 
iii.
Use of LLR or OLR for curative-intent resection of ICCA.
 
iv.
Comparing LLR versus OLR for ICCA with sufficient data including perioperative results, and long-term oncological outcomes.
 
v.
Full text available.
 
Papers were excluded if they were met any of the following:
a.
Non-English languages.
 
b.
Non-comparative analyses, animal, or laboratory studies.
 
c.
Abstracts only, meetings, books, or Letters to the Editors.
 
d.
Studies that lack adequate clinical data.
 
e.
Studies included patients with combined pathologies besides ICCA such as ICCA combined with hepatocellular carcinoma or metastatic liver diseases were excluded. Studies reported patients with perihilar, distal cholangiocarcinoma, and gallbladder cancer were also not considered.
 
f.
Studies of low quality were also excluded from the analyses.
 

Quality assessments

The quality of the included studies was assessed independently at both the individual study level and outcome level by two reviewers. The Newcastle–Ottawa Scale (NOS) [18] was used to evaluate the risk of bias of each included PSM study The NOS assessment criteria give a maximum of 9 points for risk of bias in three areas: Selection of the cohort, Comparability of exposed and nonexposed participants, and Assessment of results. Literature with a score of ≥ 7 was considered to have a low risk of bias and then was classified as high quality. (Supplementary Table S2).

Data extraction

Data extraction was conducted independently by 2 reviewers (Author 1 and Author 2), with any conflicts referred to a third reviewer (Corresponding Author) for clarification.
We gathered data from the included PSM studies. Study characteristics including but not limited to author/year of publication, research duration, study type (multicenter/single center and retrospective/prospective), and study population were extracted and are presented in Table 1. The patients’ basic demographic features and tumor characteristics in each group (LLR and OLR) such as patients' median age, gender, presence of liver cirrhosis, tumors histology, tumor number, and median diameter can be found in Supplementary Table S1.
Table 1
Characteristics of included studies
Author/year
Study type
Data origin/country
Inclusion time
Definition of LND
Definition of Major LR
LLR in total/after PSM
OLR in total/after PSM
Main conclusions
NOS score
Brustia/2022
Multi-Retro
Three independent multicenter databases/France
2000–2018
LN removal of station 12 /8/13. For left-sided tumors, station 7 and1 should also be considered
LR involving 3 or more contiguous Couinaud’s segments
146/89
709/89
Survival advantage of LLR versus OLR was observed for ICCA; LLR for ICCA seems feasible with similar rates of morbidity, compared with OLR
9
Hobeika/2021
Multi-Retro
Multiple HPB centers /France
2000–2017
Any LN harvest from hepatoduodenal ligament to the retro pancreatic and common hepatic artery area
LR involving 3 or more contiguous Couinaud’s segments
127/109
421/109
laparoscopic approach did not substantially improve quality of care of patients with resect able ICCA
8
Ratti/2020
Multi-Retro
Two European referral centers
2004–2017
Formal LND was a complete LN removal of station 8/12 and not performing LND when cirrhosis presence
Left/right or central hepatectomies
114/104
209/104
Feasibility, safety, and oncological efficiency of the laparoscopic approach in the management of ICCA
9
Ratti/2021
Single-Retro
Milan
2004–2020
Formal LND was a complete LN removal of station 8/12 and not performing LND when cirrhosis presence
LR involving 3 or more contiguous Couinaud’s segments
179/150
267/150
MIS for ICCA had advantages in perioperative outcomes and oncological non-inferior to open counterpart. OS and DFS were found to be similar between 2 approaches
8
Kang/2020
Single-Retro
Seoul
2004–2015
Metastatic LN were found/NA
LR of > 3 segments or resection of the right posterior segments
30/24
61/24
LLR for ICCA is technically feasible and safe, providing short-term benefits without increasing complications or affecting long-term survival
8
Zhu/2019
Single-Retro
China
2012–2017
LND performed only when an enlarged LN around the hepatoduodenal ligament was detected, wide lymphadenectomy was avoided
LS of > 3 segments or resection of the right posterior segments
20/18
63/36
LLR for large or multiple ICCA could obtain similar short/long-term outcomes compared to OLR, and LND was also feasible during LLR
8
Sahakyan/2023
multicenter-Retro
Four European expert centers
2012–2019
NA
LR of ≥ 3 consecutive liver segments
50/50
86/50
Laparoscopic resection seems to be associated with improved short-term and with similar long-term outcomes compared with open surgery in patients with ICCA
8
Shen/2023
Single-Retro
China
2010–2021
NA
NA
127/70
43/35
Compared with ICCA treated by OLR,the LLR group obtained superior perioperative period outcomes. LLR could enable ICC patients to receive an equivalent long-term prognosis compared to OLR
8
Yang/2022
Multi-Retro
Three independent multicenter databases in China
2011–2018
NA
LR of ≥ 3 segments or involving the posterior superior segments
150/122
645/122
laparoscopic treatment for early ICC may have certain advantages based on the long-term results; ICCA patients treated with laparoscopy seemed to have better short-term outcomes
8
Salehi/2022
Multi-Retro
NCDB databases/USA
2010–2016
NA
NA
140/115
848/115
MILR is associated with worse lymphadenectomy and survival in patients with ICCA greater than 4 cm requiring major hepatectomy
9
LND Lymph node dissection, muti-retro/single-retro multicenter/single center retrospective studies, LS/LR liver surgery/liver resection, HPB hepato-pancreato-biliary, LR liver resection, ICCA intrahepatic cholangiocarcinoma, LLR laparoscopic liver resection, OLR open liver resection, MILR minimally invasive liver resection, NA not applicable

Definitions

To help comprehensive and accurate measurement of complications that occurred after LLR and OLR, only studies that reported complications graded according to the Clavien–Dindo classification were considered for analyses. Major complications were defined as Clavien–Dindo grade III/IV in the included studies. Textbook Outcome (TO) [12] was a new composite-outcome index. The included 2 studies both considered patients with negative margins (R0), without transfusion, no severe surgical complications, prolonged hospital stay, readmissions, and no postoperative mortality as to have a TO.

Statistical analyses

The primary objective of our meta-analysis was to assess the safety, feasibility, and long-term outcomes (OS, DFS, and RFS) for resected ICCA patients after LLR and OLR. The Risk ratios (RRs) were used to assess binary variables and mean differences (MDs) to assess continuous variables. The hazard ratio (HR) for survival outcomes was calculated using the statistical method of Tierney et al. If the pooled HR and its 95%CI (confidence interval) overlapped 1, LLR had statistically comparable survival effects to OLR.
Heterogeneity between studies was assessed using Cochran’s Q test and Higgins I2 statistic. I2 values of 25%, 50%, and 75% represented low, moderate, and high levels of heterogeneity, respectively. An I2 greater than 50% (I2 > 50%) was defined as the criterion for significant heterogeneity. Random-effect models were used if significant heterogeneity emerged after the analyses. Only if the analyses showed low and/or moderate heterogeneity (I2 ≤ 50%) were fixed-effects models considered. Sensitivity analysis using the leave-one-out method was performed to assess the robustness of the results for study results with significant heterogeneity.
Potential publication bias was statistically assessed using Egger’s linear regression. A P value of greater than 0.05 for Egger’s test indicated the absence of significant statistical publication bias. To determine the effect of individual studies on the pooled estimates, sensitivity analyses were performed by serially excluding each study. Statistical significance was defined as two-tailed P values less than 0.05.
All statistical analyses were performed using RevMan software 5.3 (The Cochrane Collaboration, Oxford, UK) and R software version 4.0.0 (R Foundation for Statistical Computing, Vienna, Austria), and the Meta package was used for data analysis.

Results

Study characteristics

After comprehensive database searching and removing duplicates, 186 studies were originally identified. After a screening of titles and abstracts, 164 were removed for reasons of non-English language, single-arm analyses, case reports, reviews, letters, commentary, and conferences. Twelve studies were further evaluated for full text. Ten studies that met all inclusion criteria were finally included in the meta-analysis [16, 1927]. The flow diagram of the literature inclusion is presented in Fig. 1.
All the included studies were retrospective. According to NOS, included literature was of high quality, with 3 studies obtaining a score of 9, and 7 having a score of 8. We included 2 studies by Ratti et al. [19, 20] for the patient population in these studies were from different regions (Milan and Two European referral centers), and the research duration was also different. We summarized the baseline characteristics of the included studies in Table 1. The main outcomes of the meta-analyses are presented in Table 2
Although all included analyses were after the PSM method, given the differences in sample inclusion criteria among literature, we still compared whether important tumor characteristics differed significantly between the two groups (LLR and OLR). These indicators have been considered key factors that may influence the prognosis for ICCA patients in the previously published literature. There were no statistically significant differences in the basic demographics and tumor characteristics between the laparoscopic and open arms. Differences were noted in terms of patients in the LLR group having smaller tumor size versus OLR with SMD = − 0.13 (95% CI − 0.23 to − 0.03; P = 0.02; I2 = 0%). Both positive LN status and multiple tumor numbers (≥ 2) in the LLR group were comparable to OLR, with RR = 0.68 (95% CI 0.44–1.06, P = 0.09; I2 = 70%) and RR = 0.95; (95%CI: 0.76–1.20; P = 0.68; I2 = 0%), respectively. Significant heterogeneity was seen in the comparison of LN status in LLR versus OLR (I2 = 70%).
Table 2
Main outcomes of the meta-analyses
Short-term outcomes
Variable names
Included studies
Participants
Statistical method
Effect estimate
Perioperative outcomes
Major hepatectomy
9
1445
Risk Ratio (M–H, Fixed, 95% CI)
0.87 [0.78, 0.97]
R0 resection
7
1293
Risk Ratio (M–H, Fixed, 95% CI)
1.05 [1.01, 1.09]
LND rate
7
1106
Risk Ratio (M–H, Random, 95% CI)
0.67 [0.49, 0.91]
Major complications rates (Clavien–Dindo grade ≥ III)
9
1455
Risk Ratio (M–H, Fixed, 95% CI)
0.72 [0.56, 0.94]
90-day mortality
8
1532
Risk Ratio (M–H, Fixed, 95% CI)
0.69 [0.46, 1.03]
Textbook outcomes (TO)
2
396
Risk Ratio (M–H, Fixed, 95% CI)
1.42 [1.05, 1.92]
Retrieved lymph nodes (LN)
3
726
Mean Difference (IV, Random, 95% CI)
0.24 [-1.46, 1.94]
Liver failure after surgery
4
780
Risk Ratio (M–H, Fixed, 95% CI)
0.64 [0.32, 1.28]
Duration of hospital stay (days)
9
1507
Mean Difference (IV, Random, 95% CI)
-2.75 [-3.78, -1.71]
The conversion rate of LLR
7
1163
67/590
11.35%
Lymphatic fistula rates
2
508
Risk Ratio (M–H, Fixed, 95% CI)
0.29 [0.11, 0.79]
Biliary leakage rate
4
667
Risk Ratio (M–H, Fixed, 95% CI)
0.55 [0.28, 1.08]
Blood loss (ml)
6
933
Mean Difference (IV, Fixed, 95% CI)
-185.52 [-216.11, -156.92]
Perioperative blood transfusion rate
8
1407
Risk Ratio (M–H, Fixed, 95% CI)
0.45 [0.34, 0.59]
Duration of surgery (min)
8
1277
Mean Difference (IV, Random, 95% CI)
10.53 [-13.75, 34.81]
Postoperative Long-term results
RFS (Recurrence-free survival)
3
740
Hazard Ratio (IV, Fixed, 95% CI)
0.80 [0.63, 1.02]
OS (Overall survival)
9
 
Hazard Ratio (IV, Fixed, 95% CI)
0.91 [0.81, 1.03]
DFS (Disease-free survival)
5
 
Hazard Ratio (IV, Fixed, 95% CI)
0.95 [0.80, 1.14]
Tumor characteristics
Tumor size (cm)
9
1467
Std. Mean Difference (IV, Fixed, 95% CI)
-0.13 [-0.23, -0.03]
Positive LN status
9
1455
Risk Ratio (M–H, Random, 95% CI)
0.68 [0.44, 1.06]
Multiple tumor numbers (≥ 2)
8
1237
Risk Ratio (M–H, Fixed, 95% CI)
0.95 [0.76, 1.20]

Perioperative outcomes

With a pooled RR = 0.87 (95%CI 0.78–0.97, P = 0.01; I2 = 19%), we found that the incidence of major hepatectomy was lower in LLR than in OLR (Fig. 2a). Regarding LN dissection (LND) rates, we also found that patients after LLR group had lower LND rates than those in the OLR group (RR = 0.67; 95% CI 0.49–0.91; P = 0.01). However, there was a significant degree of heterogeneity among the included studies with I2 = 91% (Fig. 2c). Although the major hepatectomy and LND rates were lower in the LLR group, we found patients in the LLR group achieved a higher incidence of R0 resection than those in the OLR group (RR = 1.05, 95%CI 1.01–1.09, P = 0.008; I2 = 29%) (Fig. 2b).
We also determined the postoperative outcomes for patients with ICCA after LLR and OLR. Our analyses showed that compared with the OLR group, the major complications (Clavien–Dindo grade ≥ III) rate was lower for ICCA patients after LLR with RR = 0.72 (95%CI 0.56–0.94, P = 0.01; I2 = 45%) (Fig. 3a). The 90-day mortality rate was comparable between the two arms with a pooled RR = 0.69 (95%CI 0.46–1.03, P = 0.07; I2 = 1%) (Fig. 3b). Textbook outcome (TO), a novel composite measure for the surgical care quality, which represents the ideal hospitalization for patients with ICCA undergoing curative-intent resection. To compare the difference in TO between LLR and OLR, we included 2 studies with the same definitions of TO. In the end, we found that the patients in the LLR group achieved a higher TO than the patients after OLR (RR = 1.42; 95%CI: 1.05–1.92, P = 0.02). No heterogeneity was found in the analyses with I2 = 0% (Fig. 3c).
To assess the value of using LLR for ICCA more comprehensively, we have summarized other perioperative outcomes as follows: LLR resulted in lower blood loss (MD = − 185.82 ml), shorter hospital stays (MD = − 2.75 days), less lymphatic fistula incidence (RR = 0.29), and lower perioperative blood transfusion rate (RR = 0.45) than the OLR group. In addition, there was no significant heterogeneity in most of the outcomes. Nevertheless, the number of LNs harvested (MD = 0.24), the duration of surgery (MD = 10.53 min), the incidence of liver failure (RR = 0.64), and the bile leakage (RR = 0.55) rate for the patients in the LLR group were comparable to patients after OLR. The pooled results are shown in Supplementary Appendix: Figure S1, Figure S2. Finally, the conversion rate of laparoscopic procedures was reported in 7 studies and ranged between 0% and 18.0%, which is slightly lower than the results in other published literature (7.4–20%).

Postoperative long-term outcomes

Regarding the recurrence-free survival (RFS) in ICCA patients after surgery, no difference was found between LLR and OLR. Patients in the LLR group had comparable RFS compared to those with OLR (HR = 0.80, 95%CI 0.63–1.02, P = 0.07; I2 = 0%. Figure 4a). No significant difference was also resulted between LLR and OLR regarding either overall survival (OS) (HR = 0.91; 95% CI 0.81–1.03, P = 0.14; I2 = 0%; Fig. 4b) or disease-free survival (DFS) (HR = 0.95, 95% CI 0.80–1.14; P = 0.60; I2 = 38%; Fig. 4c), and there was no significant heterogeneity among the studies (I2 = 0% and 38%, respectively).

Sensitivity analyses and publication bias

Results with significant heterogeneity were pooled with the random-effect model and performed with sensitivity analyses. In our study, substantial heterogeneity was observed in the analyses of the hospital stay, surgery duration, and LND rate. After performing the sensitivity analysis using the leave-one-out method, we found no changes in the risk estimate or the level of significance in terms of these outcomes. The significant heterogeneity among the included studies may be related to the surgeon's varied experiences, different hospital volumes, and LND indications. For the assessment of publication bias, we performed Egger's test and found no significant bias in terms of length of hospital stay (P = 0.2168), surgery duration (P = 0.4558), and LND rate (P = 0.0652) (Supplementary Figure S2a–c). However, due to the limited study samples (N = 3), the publication bias for retrieved lymph nodes number objectively exists.

Discussions

For patients with ICCA, radical surgery resection for a negative margin (R0) is the only curative treatment [28, 29]. Due to the technical difficulty and uncertainty in long-term efficacy, most of the ICCA surgeries are performed under an open surgery method. LLR for ICCA is just starting, and uncertainty that exists over the subject of ICCA can be routinely solved through an LLR procedure. Only limited high-volume centers had demonstrated the feasibility and safety of LLR for ICCA. LLR technique for ICCA remained challenging at most medical centers, particularly when dealing with large (> 5 cm), multiple (> 2), or advanced ICCA tumors [11, 13, 19, 30, 31].
Published studies included different stages of ICCA in LLR and OLR; thus, the baseline characteristics of the patients were not totally matched [20, 21]. After analyzing, we found in most of the current literature, ICCA patients treated with the laparoscopy method usually had tumors of early stages and smaller sizes; thus, there is less need for large-scale hepatectomy or LND. Owing to the earlier staging of ICCA within the LLR group, previous research has not definitively established the advantages of LLR for ICCA, when compared with the OLR arm [32, 33]. Therefore, in our study, we only included PSM studies for the comparison of LLR versus OLR.
Previous studies had reported some factors including R0 resections, large tumor size, and positive LN status may influence the OS of ICCA patients. This interaction on the hand demonstrated that LLR should be performed in selected ICCA with the feasibility of adequate tumor resection and LND [20, 31, 33]. Our study found that LLR for some selected ICCA cases resulted in similar oncological and long-term survival outcomes to those of OLR, with the advantages of less blood loss, major complication rate, and shorter hospital stays. Prior studies have also shown that LLR could confer better short-term perioperative outcomes to OLR with comparable long-term survival prognosis [14, 15]. Due to smaller incisions, both wound complication rate and postoperative pain were significantly decreased in the LLR group which also help to improve the patient’s recovery. Regarding similar oncological outcomes including R0 resection and major hepatectomy rate to OLR, LLR for some selected ICCA seemed to be the optimal method.
However, LLR was associated with inferior LND in most of the published studies [14, 15] which made the effectiveness of laparoscopic LND remained controversial [32]. Martin et al. showed the laparoscopic LND rate was significantly lower than that of open surgery (39% vs. 61%, P < 0.01); while other scholars believed that the magnifying effect of laparoscopy was helpful to identify LN for a comprehensive surgery resection. Ratti et al. showed that laparoscopic LND could result in a similar number of LN to open surgery with lower complications incidence related to LND. According to the guidelines, LND was acknowledged as a standard treatment for ICCA; those conflicting published results suggested that LLR for ICCA currently may not be totally optimal [16, 19, 34].
A meta-analysis conducted by Zhou et al. suggested that LND had a limited impact on the ICCA patient's long-term prognosis, besides a higher incidence of postoperative complications was seen in the LND group. In fact, the significance of LND in ICCA was to obtain more accurate pathological staging for guiding further adjuvant treatments. Therefore, experts from the American Hepatobiliary and Pancreatic Association recommend routine LND in the ICCA treatment and suggested that at least 6 lymph nodes should be obtained after surgical resection for tumor staging. LND was to obtain adequate numbers of LN, merely comparing the LND rate in OLR and LLR may not be as important as the compassion for the average number of retrieved LN in LLR and OLR. In our analyses, we resulted in lower LND rates for ICCA after LLR compared with OLR, while in further analyses, we demonstrated a comparable average number of retrieved LN in patients with LLR and OLR. Therefore, we may conclude that LLR for selected ICCA could be practiced at experienced centers with strict ongoing practice evaluation, and the oncological efficacy was not inferior to patients with OLR.
Although more and more medical centers have carried out LLR for ICCA, we should still pay attention to the surgical indications and strictly control the quality of the surgery. The objective of surgery is to ensure R0 resection and improve patients’ survival [3539]. We still need large-scale multicenter studies to explore the safety, feasibility, surgery indications, contraindications, and long-term efficacy of LLR application in ICCA [12, 31, 32, 4044]

Strengths and limitations

Our MAs provide an updated and thorough comparison of perioperative and long-term survival outcomes for ICCA patients following LLR and OLR. However, there are several limitations to our study. First, selection bias is inherent in our included retrospective studies, and publication bias is also unavoidable due to the limited number of studies in our MAs. Besides, although we only included studies of PSM methods, other features such as tumor stages or biology behaviors may not be strictly comparable in LLR and OLR, which may confound our results. Furthermore, given that only retrospective studies were available for our MAs, it may cause a higher level of heterogeneity. In addition, there are limited studies in our MAs, and the meta-regression for some baseline characteristics on patients’ survival is not actionable, reducing our MAs’ statistical power. Finally, data from Africa and Asia were scarce, which highlighted the need for more multicenter studies.

Conclusions

LLR for selected ICCA patients may be technically safe and feasible, providing short-term benefits and achieving oncological efficacy without compromising the long-term survival of the patients. Although an increasing number of medical centers have been performing LLR for ICCA, the procedure is still in the initial phase of exploration. More evidence is needed to validate the use of LLR for ICCA.

Declarations

Conflicts of interest

All authors declare have no conflicts of interest to disclose.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Lee YT, Wang JJ, Luu M et al (2021) Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States. Hepatology 74(5):2622–2632PubMedCrossRef Lee YT, Wang JJ, Luu M et al (2021) Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States. Hepatology 74(5):2622–2632PubMedCrossRef
2.
Zurück zum Zitat Mukund A, Srinivasan SV, Rana S et al (2022) Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study. Clin Radiol 77(2):121–129PubMedCrossRef Mukund A, Srinivasan SV, Rana S et al (2022) Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study. Clin Radiol 77(2):121–129PubMedCrossRef
3.
Zurück zum Zitat Kendall T, Verheij J, Gaudio E et al (2019) Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int 39(Suppl 1):7–18PubMedCrossRef Kendall T, Verheij J, Gaudio E et al (2019) Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int 39(Suppl 1):7–18PubMedCrossRef
4.
Zurück zum Zitat Bagante F, Spolverato G, Merath K et al (2019) Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection. Surgery 166(6):983–990PubMedCrossRef Bagante F, Spolverato G, Merath K et al (2019) Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection. Surgery 166(6):983–990PubMedCrossRef
5.
Zurück zum Zitat Mavros MN, Economopoulos KP, Alexiou VG et al (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149(6):565–574PubMedCrossRef Mavros MN, Economopoulos KP, Alexiou VG et al (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149(6):565–574PubMedCrossRef
6.
Zurück zum Zitat Liu WR, Tian MX, Tao CY et al (2020) Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis. BMC Cancer 20(1):642PubMedPubMedCentralCrossRef Liu WR, Tian MX, Tao CY et al (2020) Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis. BMC Cancer 20(1):642PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Birgin E, Kaslow SR, Hetjens S et al (2021) Minimally invasive versus open liver resection for stage I/II hepatocellular carcinoma. Cancers (Basel) 13(19):4800PubMedCrossRef Birgin E, Kaslow SR, Hetjens S et al (2021) Minimally invasive versus open liver resection for stage I/II hepatocellular carcinoma. Cancers (Basel) 13(19):4800PubMedCrossRef
8.
Zurück zum Zitat Levi Sandri GB, Colasanti M, Aldrighetti L et al (2022) Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry. Updates Surg 74(1):87–96PubMedCrossRef Levi Sandri GB, Colasanti M, Aldrighetti L et al (2022) Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry. Updates Surg 74(1):87–96PubMedCrossRef
9.
Zurück zum Zitat Mejia JC, Pasko J (2020) Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Surg Clin North Am 100(3):535–549PubMedCrossRef Mejia JC, Pasko J (2020) Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Surg Clin North Am 100(3):535–549PubMedCrossRef
10.
Zurück zum Zitat Patrone R, Izzo F, Palaia R et al (2021) Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: a systematic review. World J Gastrointest Oncol 13(12):2203–2215PubMedPubMedCentralCrossRef Patrone R, Izzo F, Palaia R et al (2021) Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: a systematic review. World J Gastrointest Oncol 13(12):2203–2215PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Shiraiwa DK, Carvalho P, Maeda CT et al (2020) The role of minimally invasive hepatectomy for hilar and intrahepatic cholangiocarcinoma: a systematic review of the literature. J Surg Oncol 121(5):863–872PubMedCrossRef Shiraiwa DK, Carvalho P, Maeda CT et al (2020) The role of minimally invasive hepatectomy for hilar and intrahepatic cholangiocarcinoma: a systematic review of the literature. J Surg Oncol 121(5):863–872PubMedCrossRef
12.
Zurück zum Zitat Görgec B, Benedetti Cacciaguerra A, Lanari J et al (2021) Assessment of textbook outcome in laparoscopic and open liver surgery. JAMA Surg 156(8):e212064PubMedPubMedCentralCrossRef Görgec B, Benedetti Cacciaguerra A, Lanari J et al (2021) Assessment of textbook outcome in laparoscopic and open liver surgery. JAMA Surg 156(8):e212064PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Machairas N, Lang H, Jayant K et al (2020) Intrahepatic cholangiocarcinoma: limitations for resectability, current surgical concepts and future perspectives. Eur J Surg Oncol 46(5):740–746PubMedCrossRef Machairas N, Lang H, Jayant K et al (2020) Intrahepatic cholangiocarcinoma: limitations for resectability, current surgical concepts and future perspectives. Eur J Surg Oncol 46(5):740–746PubMedCrossRef
14.
Zurück zum Zitat Regmi P, Hu HJ, Paudyal P et al (2021) Is laparoscopic liver resection safe for intrahepatic cholangiocarcinoma? A meta-analysis. Eur J Surg Oncol 47(5):979–989PubMedCrossRef Regmi P, Hu HJ, Paudyal P et al (2021) Is laparoscopic liver resection safe for intrahepatic cholangiocarcinoma? A meta-analysis. Eur J Surg Oncol 47(5):979–989PubMedCrossRef
15.
Zurück zum Zitat Ziogas IA, Esagian SM, Giannis D et al (2021) Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma: an individual patient data survival meta-analysis. Am J Surg 222(4):731–738PubMedCrossRef Ziogas IA, Esagian SM, Giannis D et al (2021) Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma: an individual patient data survival meta-analysis. Am J Surg 222(4):731–738PubMedCrossRef
16.
Zurück zum Zitat Hobeika C, Cauchy F, Fuks D et al (2021) Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis. Br J Surg 108(4):419–426PubMedCrossRef Hobeika C, Cauchy F, Fuks D et al (2021) Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis. Br J Surg 108(4):419–426PubMedCrossRef
17.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535PubMedPubMedCentralCrossRef Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Ratti F, Casadei-Gardini A, Cipriani F et al (2021) Laparoscopic surgery for intrahepatic cholangiocarcinoma: a focus on oncological outcomes. J Clin Med 10(13):2828PubMedPubMedCentralCrossRef Ratti F, Casadei-Gardini A, Cipriani F et al (2021) Laparoscopic surgery for intrahepatic cholangiocarcinoma: a focus on oncological outcomes. J Clin Med 10(13):2828PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Ratti F, Rawashdeh A, Cipriani F et al (2021) Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections. Surg Endosc 35(4):1851–1862PubMedCrossRef Ratti F, Rawashdeh A, Cipriani F et al (2021) Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections. Surg Endosc 35(4):1851–1862PubMedCrossRef
21.
Zurück zum Zitat Brustia R, Laurent A, Goumard C et al (2022) Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: report of an international multicenter cohort study with propensity score matching. Surgery 171(5):1290–1302PubMedCrossRef Brustia R, Laurent A, Goumard C et al (2022) Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: report of an international multicenter cohort study with propensity score matching. Surgery 171(5):1290–1302PubMedCrossRef
22.
Zurück zum Zitat Jinhuan Y, Yi W, Yuanwen Z et al (2021) Laparoscopic versus open surgery for early-stage intrahepatic cholangiocarcinoma after mastering the learning curve: a multicenter data-based matched study. Front Oncol 11:742544PubMedCrossRef Jinhuan Y, Yi W, Yuanwen Z et al (2021) Laparoscopic versus open surgery for early-stage intrahepatic cholangiocarcinoma after mastering the learning curve: a multicenter data-based matched study. Front Oncol 11:742544PubMedCrossRef
23.
Zurück zum Zitat Salehi O, Kazakova V, Vega EA et al (2022) Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score-matched analysis using the national cancer database. Surg Endosc 36(7):5382–5391PubMedCrossRef Salehi O, Kazakova V, Vega EA et al (2022) Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score-matched analysis using the national cancer database. Surg Endosc 36(7):5382–5391PubMedCrossRef
24.
Zurück zum Zitat Kang SH, Choi Y, Lee W et al (2020) Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surg Oncol 33:63–69PubMedCrossRef Kang SH, Choi Y, Lee W et al (2020) Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surg Oncol 33:63–69PubMedCrossRef
25.
Zurück zum Zitat Zhu Y, Song J, Xu X et al (2019) Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas: a propensity score-based case-matched analysis from a single institute. Medicine (Baltimore) 98(49):e18307PubMedCrossRef Zhu Y, Song J, Xu X et al (2019) Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas: a propensity score-based case-matched analysis from a single institute. Medicine (Baltimore) 98(49):e18307PubMedCrossRef
26.
Zurück zum Zitat Sahakyan MA, Aghayan DL, Edwin B (2023) Laparoscopic versus open liver resection. For intrahepatic cholangiocarcinoma: a multicenter propensity score-matched study. Scand J Gastroenterol 58(5):489–496 (Epub 2022 Nov 14)PubMedCrossRef Sahakyan MA, Aghayan DL, Edwin B (2023) Laparoscopic versus open liver resection. For intrahepatic cholangiocarcinoma: a multicenter propensity score-matched study. Scand J Gastroenterol 58(5):489–496 (Epub 2022 Nov 14)PubMedCrossRef
27.
Zurück zum Zitat Shen Z, Tao L, Cai J, Zheng J, Sheng Y, Yang Z, Gong L, Song C, Gao J, Ying H, Xu J, Liang X (2023) Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched study. World J Surg Oncol 21(1):126PubMedPubMedCentralCrossRef Shen Z, Tao L, Cai J, Zheng J, Sheng Y, Yang Z, Gong L, Song C, Gao J, Ying H, Xu J, Liang X (2023) Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched study. World J Surg Oncol 21(1):126PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Rizvi S, Khan SA, Hallemeier CL et al (2018) Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15(2):95–111PubMedCrossRef Rizvi S, Khan SA, Hallemeier CL et al (2018) Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15(2):95–111PubMedCrossRef
29.
Zurück zum Zitat Kelley RK, Bridgewater J, Gores GJ et al (2020) Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol 72(2):353–363PubMedCrossRef Kelley RK, Bridgewater J, Gores GJ et al (2020) Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol 72(2):353–363PubMedCrossRef
30.
Zurück zum Zitat Mazzaferro V, Gorgen A, Roayaie S et al (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72(2):364–377PubMedCrossRef Mazzaferro V, Gorgen A, Roayaie S et al (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72(2):364–377PubMedCrossRef
32.
Zurück zum Zitat Wu J, Han J, Zhang Y et al (2020) Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends 14(5):376–383PubMedCrossRef Wu J, Han J, Zhang Y et al (2020) Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends 14(5):376–383PubMedCrossRef
33.
Zurück zum Zitat Lee W, Park JH, Kim JY et al (2016) Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc 30(11):4835–4840PubMedCrossRef Lee W, Park JH, Kim JY et al (2016) Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc 30(11):4835–4840PubMedCrossRef
34.
Zurück zum Zitat Kim-Fuchs C, Candinas D, Lachenmayer A (2021) The role of conventional and stereotactic microwave ablation for intrahepatic cholangiocarcinoma. J Clin Med 10(13):2963PubMedPubMedCentralCrossRef Kim-Fuchs C, Candinas D, Lachenmayer A (2021) The role of conventional and stereotactic microwave ablation for intrahepatic cholangiocarcinoma. J Clin Med 10(13):2963PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Wei F, Lu C, Cai L et al (2017) Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas? Surg Endosc 31(9):3646–3655PubMedCrossRef Wei F, Lu C, Cai L et al (2017) Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas? Surg Endosc 31(9):3646–3655PubMedCrossRef
36.
Zurück zum Zitat Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31(9):1188–1195PubMedCrossRef Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31(9):1188–1195PubMedCrossRef
37.
Zurück zum Zitat Kinoshita M, Kanazawa A, Takemura S et al (2020) Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma. Asian J Endosc Surg 13(1):46–58PubMedCrossRef Kinoshita M, Kanazawa A, Takemura S et al (2020) Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma. Asian J Endosc Surg 13(1):46–58PubMedCrossRef
38.
Zurück zum Zitat Panayotova GG, Guarrera JV, Lunsford KE (2020) Should we reevaluate liver transplantation as an alternative to resection for the treatment of intrahepatic cholangiocarcinoma? Liver Transpl 26(6):748–750PubMedCrossRef Panayotova GG, Guarrera JV, Lunsford KE (2020) Should we reevaluate liver transplantation as an alternative to resection for the treatment of intrahepatic cholangiocarcinoma? Liver Transpl 26(6):748–750PubMedCrossRef
39.
Zurück zum Zitat Ji GW, Jiao CY, Xu ZG et al (2022) Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma. BMC Cancer 22(1):258PubMedPubMedCentralCrossRef Ji GW, Jiao CY, Xu ZG et al (2022) Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma. BMC Cancer 22(1):258PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Farges O, Regimbeau JM, Fuks D et al (2013) Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100(2):274–283PubMedCrossRef Farges O, Regimbeau JM, Fuks D et al (2013) Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100(2):274–283PubMedCrossRef
41.
Zurück zum Zitat Molina V, Ferrer-Fábrega J, Sampson-Dávila J et al (2020) Intention-to-treat curative liver resection in patients with “very early” intrahepatic cholangiocarcinoma. Langenbecks Arch Surg 405(7):967–975PubMedCrossRef Molina V, Ferrer-Fábrega J, Sampson-Dávila J et al (2020) Intention-to-treat curative liver resection in patients with “very early” intrahepatic cholangiocarcinoma. Langenbecks Arch Surg 405(7):967–975PubMedCrossRef
42.
Zurück zum Zitat Sapisochin G, Ivanics T, Heimbach J (2022) Liver Transplantation for intrahepatic cholangiocarcinoma: ready for prime time? Hepatology 75(2):455–472PubMedCrossRef Sapisochin G, Ivanics T, Heimbach J (2022) Liver Transplantation for intrahepatic cholangiocarcinoma: ready for prime time? Hepatology 75(2):455–472PubMedCrossRef
43.
Zurück zum Zitat Moustafa M, Fasolo E, Bassi D et al (2020) The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: a propensity score analysis. Eur J Surg Oncol 46(4 Pt A):632–637PubMedCrossRef Moustafa M, Fasolo E, Bassi D et al (2020) The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: a propensity score analysis. Eur J Surg Oncol 46(4 Pt A):632–637PubMedCrossRef
44.
Zurück zum Zitat Tarchi P, Tabrizian P, Prigoff J et al (2018) Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma. Surgery 163(4):698–702PubMedCrossRef Tarchi P, Tabrizian P, Prigoff J et al (2018) Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma. Surgery 163(4):698–702PubMedCrossRef
Metadaten
Titel
Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a systematic review of propensity score-matched studies
verfasst von
Ya-Fei Hu
Hai-Jie Hu
Wen-Jie Ma
Yan-Wen Jin
Fu-Yu Li
Publikationsdatum
02.11.2023
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 8/2023
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-023-01648-8

Weitere Artikel der Ausgabe 8/2023

Updates in Surgery 8/2023 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.